VIDEO: When enough is too much

Article

Optometrist Ben Casella explains a glaucoma case and finding the right medication dosage.

Read the full story here.
 

Recent Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Dr Nate Lighthizer discusses his 2024 Vision Expo West presentations
Jeffry Gerson, OD, FAAO, chats with Optometry Times about his talks about retina conditions at Vision Expo West
Danica Marrelli, OD, FAAO, AAO Dip, talks OCT and glaucoma
Ben Casella, OD, FAAO, talks 2024 EyeCon's networking and education opportunities
EyeCon Co-chair Oluwatosin U. Smith, MD talks passion for research and education in ophthalmology
Lorraine Provencher, MD, presenting slides
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Related Content
IOP detecting sensor and its applicator Image credit: Injectsense

Injectsense announces first human implant of ultraminiature IOP sensor

Jordana Joy, Associate Editor
August 29th 2024
Article
Expanding the treatment arsenal in glaucoma management

Expanding the treatment arsenal in glaucoma management

Melissa Tawa, OD, FAAO;Deborah Ristvedt, DO;Inder Paul Singh, MD;Arsham Sheybani, MD
August 31st 2024
Podcast
People stretching in a field Image credit: ©Halfpoint - adobe.stock.com

Study evaluates impact of exercise on intraocular pressure in glaucoma patients

Lynda Charters
August 23rd 2024
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Patient in office waiting for eye exam Image credit: ©lightpoet - adobe.stock.com

How to identify treatment failure and initiate medication switches

Mark E. Schaeffer, OD, FAAO
July 30th 2024
Article
Patient speaking to doctor in office Image credit: ©Jacob Lund - adobe.stock.com

Nicox announces recruitment of last US patient in Denali Phase 3 trial of NCX 470

David Hutton, Managing Editor, Ophthalmology Times
July 29th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.